ÂÜÀòÂÒÂ×

Atul Chopra is a distinguished medical professional with extensive experience in genetics and hormone research. Currently serving as a Harrington Investigator at the Harrington Discovery Institute at University Hospitals since July 2018, Atul Chopra focuses on the hormone Asprosin, which is linked to appetite regulation and glucose metabolism, particularly in the context of obesity and diabetes. Additionally, Atul Chopra is a Co-Founder and Chief Scientific Officer at Aceragen and serves on its Board of Directors. As an Attending Medical Geneticist at the Center for Human Genetics at University Hospitals Cleveland Medical Center, Atul Chopra applies expertise in their field to clinical practice. Previous roles include Physician Scientist at Baylor College of Medicine and residency in Medical Genetics at Texas Children's Hospital, further complemented by a Doctorate from Baylor College of Medicine and medical training at MIMER Medical College.